Frank Armstrong
Director/Board Member at ECO ANIMAL HEALTH GROUP PLC
Net worth: 126 673 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elaine C. Stracker | M | 64 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
| Andrew Booth | M | - | 9 years | |
| Christoph Wiessner | M | - |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | 12 years |
| Christopher Wilks | M | 60 | 5 years | |
| Denise Scots-Knight | M | 64 | 9 years | |
| Adrien Lemoine | M | - |
Bloomsbury Genetic Therapies Ltd.
 Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 3 years |
| Andrew Alfred Jones | M | 64 | 7 years | |
| Michael Diem | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | - |
| Bill Webb | M | - |
The University of Edinburgh
| - |
| Alison Jane Williamson | F | - |
BioCaptiva Ltd.
 BioCaptiva Ltd. BiotechnologyHealth Technology BioCaptiva Ltd. is a British medical device company that is developing the BioCaptis, a device that can transform liquid biopsy testing for cancer management. The company is based in Edinburgh, UK. The BioCaptis captures up to 100x more cell-free DNA (cfDNA) than a venous blood draw, yielding high-quality and quantity cfDNA for testing, which addresses the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BioCaptiva was founded in 2021 when it spun out from the University of Edinburgh. The CEO is Jeremy Wheeler. | 2 years |
| Andrea Spezzi | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
| Lyle Armstrong | M | - |
Newcells Biotech Ltd.
 Newcells Biotech Ltd. BiotechnologyHealth Technology Newcells Biotech Ltd. operates as a biotechnology company which produces induced pluripotent stem cells and reproducible cell and tissues. Its cell products include human neural progenitor and cardiomyocyte. The firm also provides reprogramming and differentiation services and products. The company was founded by Majlinda Lako and Lyle Armstrong in 2014 and is headquartered in Newcastle Upon Tyne, the United Kingdom. | - |
| Andrew Buglass | M | 52 | - | |
| John Poulos | M | 70 | 7 years | |
| Anders Olof Adolf Ekblom | M | 70 | 9 years | |
| Tracey James | F | 62 | 3 years | |
| Marie-Louise Fjaellskog | M | 59 | 2 years | |
| Jeremy Wheeler | M | 58 |
BioCaptiva Ltd.
BioCaptiva Ltd. BiotechnologyHealth Technology BioCaptiva Ltd. is a British medical device company that is developing the BioCaptis, a device that can transform liquid biopsy testing for cancer management. The company is based in Edinburgh, UK. The BioCaptis captures up to 100x more cell-free DNA (cfDNA) than a venous blood draw, yielding high-quality and quantity cfDNA for testing, which addresses the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BioCaptiva was founded in 2021 when it spun out from the University of Edinburgh. The CEO is Jeremy Wheeler. | - |
| David Charles Hallas | M | 60 | 2 years | |
| John Ilett | M | - |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | 2 years |
| Craig Steele | M | - |
Pharmaron Abs, Inc.
 Pharmaron Abs, Inc. Pharmaceuticals: MajorHealth Technology Xceleron, Inc. provides drug development and biomedical research services. Its services include pharmaceutical and analytical method quality. The company was founded by Colin Garner in 1997 and is headquartered in Germantown, MD. | 12 years |
| Tuomo Tapani Pätsi | M | 60 | 1 years | |
| Bernhard Kirschbaum | M | 65 | 8 years | |
| Stephen Lockhart | M | 67 |
The Royal College of Physicians
| 41 years |
| Stuart Ungar | M | 80 |
The Royal College of Physicians
| - |
| Mike Anderson | M | - |
The Royal College of Physicians
| - |
| Rupert Vessey | M | 59 |
The Royal College of Physicians
| - |
| John Bonnar | M | - |
The Royal College of Physicians
| - |
| Harry Solomon | M | 87 |
The Royal College of Physicians
| - |
| John Anderson | M | - |
The Royal College of Physicians
| - |
| Ka Wah Hui | M | 60 |
The Royal College of Physicians
| - |
| Martin Edwards | M | 68 |
The Royal College of Physicians
| - |
| Zaki Morad bin Mohamad Zaher | M | 74 |
The Royal College of Physicians
| - |
| Peter Richardson | M | 64 |
The Royal College of Physicians
| - |
| Ka Shing Yan | M | 38 |
The Royal College of Physicians
| - |
| David Shapiro | M | 69 |
The Royal College of Physicians
| - |
| Man Yung Cheng | M | 74 |
The Royal College of Physicians
| 44 years |
| Herman Waldmann | M | - |
The Royal College of Physicians
| - |
| Alexandra Sinclair | M | - |
The Royal College of Physicians
| - |
| Steve Knowles | M | - |
The Royal College of Physicians
| - |
| Rosh Dias | M | - |
The Royal College of Physicians
| - |
| Richard Philipson | M | 60 |
The Royal College of Physicians
| - |
| Ik King Tiong | M | 74 |
The Royal College of Physicians
| 47 years |
| Roger A. Perrault | M | 87 |
The Royal College of Physicians
| 44 years |
| Karen Atkin | M | 58 |
The Royal College of Physicians
| - |
| Essra Ridha | M | 41 |
The Royal College of Physicians
| - |
| Monica Shaw | M | 46 |
The Royal College of Physicians
| - |
| Ash Soman | M | - |
The Royal College of Physicians
| - |
| Arvind Balakrishna Kasaragod | M | - |
The Royal College of Physicians
| - |
| Ray Tallis | M | - |
The Royal College of Physicians
| - |
| Henry Y. Pan | M | 77 |
The Royal College of Physicians
| - |
| Andrew Allen | M | 57 |
The Royal College of Physicians
| - |
| Lindsey Rolfe | M | 56 |
The Royal College of Physicians
| - |
| Suyash Prasad | M | 54 |
The Royal College of Physicians
| - |
| Peter Dewis | M | - |
The Royal College of Physicians
| - |
| Preetinder Singh Joshi | M | 75 |
The Royal College of Physicians
| 46 years |
| Emmet B. Keeffe | M | - |
The Royal College of Physicians
| - |
| Alan Keith Boyd | M | 70 |
The Royal College of Physicians
| - |
| Felicity Gabbay | M | 72 |
The Royal College of Physicians
| - |
| Caroline Dumas | M | - |
The Royal College of Physicians
| - |
| Simon Long | M | - |
The Royal College of Physicians
| - |
| Chrisantha Nicholas Nonis | M | - |
The Royal College of Physicians
| - |
| Ramesh Kancharla | M | 62 |
The Royal College of Physicians
| - |
| Akshay Vaishnaw | M | 61 |
The Royal College of Physicians
| - |
| Stephen D. Wise | M | - |
The Royal College of Physicians
| - |
| Paul Kenna | M | - |
The Royal College of Physicians
| - |
| Lewis J. Rubin | M | - |
The Royal College of Physicians
| - |
| James Shannon | M | 67 |
The Royal College of Physicians
| - |
| Kim Chan Koh | M | - |
The Royal College of Physicians
| - |
| Hilary McElwaine-Johnn | M | - |
The Royal College of Physicians
| - |
| Janice Brown | F | 69 |
The University of Edinburgh
| - |
| Peter Gardiner | M | - |
The Royal College of Physicians
| - |
| Chee Siong Soo | M | 63 |
The Royal College of Physicians
| - |
| Charles Q. Morris | M | 59 |
The Royal College of Physicians
| - |
| Adam Craig | M | 58 |
The Royal College of Physicians
| - |
| Christopher Ball | M | - |
The Royal College of Physicians
| - |
| Brian John O’Keeffe | M | - |
The Royal College of Physicians
| - |
| Sanjay Rajpara | M | - |
The Royal College of Physicians
| - |
| Andrew Richard Rut | M | 63 |
The Royal College of Physicians
| - |
| Kemal Malik | M | 61 |
The Royal College of Physicians
| - |
| Stephen L. Bandak | M | 74 |
The Royal College of Physicians
| 47 years |
| Kei Siong Khoo | M | 62 |
The Royal College of Physicians
| - |
| Abdur Rahman Khan | M | 90 |
The Royal College of Physicians
| - |
| Alan Suggett | M | 80 |
The Royal College of Physicians
| - |
| Warren Cooper | M | 71 |
The Royal College of Physicians
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Condella | M | 70 |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | 8 years |
| Valerie Lynne Andrews | F | 64 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 14 years |
| Jeffrey E. Young | M | 51 | 1 years | |
| Leopoldo Giampaolo Zambeletti | M | 55 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 9 years |
| Dirk Beher | M | - |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | 11 years |
| Peter John Fellner | M | 80 | 7 years | |
| George Elston | M | 59 | 2 years | |
| Stephen Davies | M | 74 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 15 years |
| Jonathan B. Lloyd Jones | M | 63 | 1 years | |
| Belén Garijo López | M | 62 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 4 years |
| David Roblin | M | 57 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 6 years |
| Alicia Secor | F | 62 | 2 years | |
| Matti Esa Manner | M | 71 | 19 years | |
| Neill Moray MacKenzie | M | - |
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 87 | 87.88% |
| United States | 7 | 7.07% |
| Finland | 5 | 5.05% |
| Switzerland | 3 | 3.03% |
| Germany | 1 | 1.01% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank Armstrong
- Personal Network
